BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28539564)

  • 21. Randomized, double-blind pilot study of transendocardial injection of autologous aldehyde dehydrogenase-bright stem cells in patients with ischemic heart failure.
    Perin EC; Silva GV; Zheng Y; Gahremanpour A; Canales J; Patel D; Fernandes MR; Keller LH; Quan X; Coulter SA; Moore WH; Herlihy JP; Willerson JT
    Am Heart J; 2012 Mar; 163(3):415-21, 421.e1. PubMed ID: 22424012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brachial approach to NOGA-guided procedures: electromechanical mapping and transendocardial stem-cell injections.
    Banovic M; Ostojic MC; Bartunek J; Nedeljkovic M; Beleslin B; Terzic A
    Tex Heart Inst J; 2011; 38(2):179-82. PubMed ID: 21494532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracoronary delivery of bone-marrow-derived stem cells.
    Bui QT; Gertz ZM; Wilensky RL
    Stem Cell Res Ther; 2010 Sep; 1(4):29. PubMed ID: 20863415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Transcatheter cell therapy of heart failure: state of the art].
    D'Ambrosio A; Di Sciascio G
    G Ital Cardiol (Rome); 2006 Jan; 7(1):23-39. PubMed ID: 16528960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MRI evaluation of local myocardial treatments: epicardial versus endocardial (Cell-Fix catheter) injections.
    Chachques JC; Azarine A; Mousseaux E; El Serafi M; Cortes-Morichetti M; Carpentier AF
    J Interv Cardiol; 2007 Jun; 20(3):188-96. PubMed ID: 17524110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac accumulation of bone marrow mononuclear progenitor cells after intracoronary or intravenous injection in pigs subjected to acute myocardial infarction with subsequent reperfusion.
    Grøgaard HK; Sigurjonsson OE; Brekke M; Kløw NE; Landsverk KS; Lyberg T; Eriksen M; Egeland T; Ilebekk A
    Cardiovasc Revasc Med; 2007; 8(1):21-7. PubMed ID: 17293265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracoronary delivery of autologous bone marrow mononuclear cells radiolabeled by 18F-fluoro-deoxy-glucose: tissue distribution and impact on post-infarct swine hearts.
    Qian H; Yang Y; Huang J; Gao R; Dou K; Yang G; Li J; Shen R; He Z; Lu M; Zhao S
    J Cell Biochem; 2007 Sep; 102(1):64-74. PubMed ID: 17407141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The feasibility and safety of transendocardial gene injection in canine using a multifunctional intracardiac echocardiography catheter.
    Guo R; Qian J; Yang Y; Zhou D; Zhu Q; Liu D; Deng C; Wang Z; Huang J
    Int J Cardiol; 2013 May; 165(3):488-93. PubMed ID: 21985752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transendocardial autologous bone marrow in chronic myocardial infarction using a helical needle catheter: 1-year follow-up in an open-label, nonrandomized, single-center pilot study (the TABMMI study).
    de la Fuente LM; Stertzer SH; Argentieri J; Peñaloza E; Miano J; Koziner B; Bilos C; Altman PA
    Am Heart J; 2007 Jul; 154(1):79.e1-7. PubMed ID: 17584556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percutaneous intramyocardial delivery of mesenchymal stem cells induces superior improvement in regional left ventricular function compared with bone marrow mononuclear cells in porcine myocardial infarcted heart.
    Tao B; Cui M; Wang C; Ma S; Wu F; Yi F; Qin X; Liu J; Wang H; Wang Z; Ma X; Tian J; Chen Y; Wang J; Cao F
    Theranostics; 2015; 5(2):196-205. PubMed ID: 25553108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Xenotransplantation of Human Cardiomyocyte Progenitor Cells Does Not Improve Cardiac Function in a Porcine Model of Chronic Ischemic Heart Failure. Results from a Randomized, Blinded, Placebo Controlled Trial.
    Jansen of Lorkeers SJ; Gho JM; Koudstaal S; van Hout GP; Zwetsloot PP; van Oorschot JW; van Eeuwijk EC; Leiner T; Hoefer IE; Goumans MJ; Doevendans PA; Sluijter JP; Chamuleau SA
    PLoS One; 2015; 10(12):e0143953. PubMed ID: 26678993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials.
    Hou D; Youssef EA; Brinton TJ; Zhang P; Rogers P; Price ET; Yeung AC; Johnstone BH; Yock PG; March KL
    Circulation; 2005 Aug; 112(9 Suppl):I150-6. PubMed ID: 16159808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. (18)F-FDG cell labeling may underestimate transplanted cell homing: more accurate, efficient, and stable cell labeling with hexadecyl-4-[(18)F]fluorobenzoate for in vivo tracking of transplanted human progenitor cells by positron emission tomography.
    Zhang Y; Dasilva JN; Hadizad T; Thorn S; Kuraitis D; Renaud JM; Ahmadi A; Kordos M; Dekemp RA; Beanlands RS; Suuronen EJ; Ruel M
    Cell Transplant; 2012; 21(9):1821-35. PubMed ID: 22469629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A transendocardial delivery and intracardiac ultrasound irradiation treatment catheter.
    Yuan QY; Huang J; Li XJ; Peng JB; Li XS; Chen ZP; Si LY
    Drug Deliv; 2013 Aug; 20(6):252-7. PubMed ID: 23789730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endocardial electrogram analysis after intramyocardial injection of mesenchymal stem cells in the chronic ischemic myocardium.
    Krause K; Schneider C; Lange C; Kokturk B; Boczor S; Geidel S; Salhi A; Alaser J; Zander AR; Kuck KH; Jaquet K
    Pacing Clin Electrophysiol; 2009 Oct; 32(10):1319-28. PubMed ID: 19694971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intramyocardial delivery of FGF2 in combination with radio frequency transmyocardial revascularization.
    Bao J; Naimark W; Palasis M; Laham R; Simons M; Post MJ
    Catheter Cardiovasc Interv; 2001 Jul; 53(3):429-34. PubMed ID: 11458429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new strategy for septal ablation with transendocardial ethanol injection using a multifunctional intracardiac echocardiography catheter: a feasibility study in canines.
    Guo R; Qian J; Yang Y; Zhu Q; Liu D; Deng C; Wang Z; Huang J
    Catheter Cardiovasc Interv; 2011 Aug; 78(2):316-23. PubMed ID: 21542125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transendocardial autologous bone marrow mononuclear cell injection in ischemic heart failure: postmortem anatomicopathologic and immunohistochemical findings.
    Dohmann HF; Perin EC; Takiya CM; Silva GV; Silva SA; Sousa AL; Mesquita CT; Rossi MI; Pascarelli BM; Assis IM; Dutra HS; Assad JA; Castello-Branco RV; Drummond C; Dohmann HJ; Willerson JT; Borojevic R
    Circulation; 2005 Jul; 112(4):521-6. PubMed ID: 16027258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy.
    Perin EC; Dohmann HF; Borojevic R; Silva SA; Sousa AL; Silva GV; Mesquita CT; Belém L; Vaughn WK; Rangel FO; Assad JA; Carvalho AC; Branco RV; Rossi MI; Dohmann HJ; Willerson JT
    Circulation; 2004 Sep; 110(11 Suppl 1):II213-8. PubMed ID: 15364865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heart regeneration: what cells to use and how?
    Tousoulis D; Briasoulis A; Antoniades C; Stefanadi E; Stefanadis C
    Curr Opin Pharmacol; 2008 Apr; 8(2):211-8. PubMed ID: 18291721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.